With the analysis among 146 patents, we discovered top 35 key players by total patent application. THERIPION, INC., Human Genome Sciences, Inc., Mitsubishi Tanabe Pharma Corp. are dominant in this area. They take 30.14% of the total patent filing.
Osaka-fu, Japan
Patent: 12
Gyeonggi-do, South Korea
Patent: 7
Michigan, United States
Patent: 6
No data, please try another search term
With the analysis among related 29 patents applied in the last 5 years. We discover 9 most active companies in this area. The fast-growing THERIPION, INC., Glaceum Inc, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) take 68.97% of patent filing during this period.
Gyeonggi-do, South Korea
Patent: 7
Jiangsu Sheng, China
Patent: 1
Beijing Shi, China
Patent: 1
Hubei Sheng, China
Patent: 1
District of Columbia, United States
Patent: 1
Shanghai Shi, China
Patent: 1
With the analysis among related 29 patents in last 5 years, we discover 6 new entrants. Glaceum Inc, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Suzhou Prius Biotechnology Co., Ltd. are the most active new entrants in this area.
Gyeonggi-do, South Korea
Patent: 7
Jiangsu Sheng, China
Patent: 1
Beijing Shi, China
Patent: 1
Shanghai Shi, China
Patent: 1
With the analysis among 27 patents, we discovered top 8 universities and scientific research institutions by total patent application. University of Washington, Wuhan University, Katholieke Universiteit Leuven are dominant in this area. They take 29.63% of the total patent filing.
Washington, United States
Patent: 2
Hubei Sheng, China
Patent: 2
Vlaams-Brabant, Belgium
Patent: 1
Jiangsu Sheng, China
Patent: 1
Xinjiang Uygur Zizhiqu, China
Patent: 1
Henan Sheng, China
Patent: 1
Henan Sheng, China
Patent: 1